Status:
COMPLETED
Dexmedetomidine on Pediatric Heart Operation
Lead Sponsor:
Gachon University Gil Medical Center
Conditions:
Acute Renal Injury
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients
Detailed Description
dexmedetomidine, a2-adrenoreceptor agonist has been used for sedation or hemodynamic stability for operative procedure. It had been already reported that dexmedetomidine reduce the impairment of renal...
Eligibility Criteria
Inclusion
- 1-6yr pediatric cardiac patients
Exclusion
- previous renal dysfunction
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01920542
Start Date
September 1 2013
End Date
August 1 2016
Last Update
November 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gachon University Gil Medical Cneter
Incheon, South Korea